Skip to main content
Wally Smith, MD, Internal Medicine, Richmond, VA

WallyRSmithMD

Internal Medicine • Richmond, VA

Professor, Internal Medicine, Virginia Commonwealth University, Medical College of Virginia School of Medicine

Join to view full profile

Dr. Smith is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Smith's full profile

Already have an account?

  • Office

    1250 East Marshall Street
    Internal Medicine
    Richmond, VA 23298
    Phone+1 804-828-9690
    Fax+1 804-828-5566

Education & Training

  • University of Alabama Medical Center
    University of Alabama Medical CenterInternship, Internal Medicine, 1981 - 1982
  • University of Alabama School of Medicine
    University of Alabama School of MedicineClass of 1981

Certifications & Licensure

  • VA State Medical License
    VA State Medical License 1991 - 2026
  • TN State Medical License
    TN State Medical License 1983 - 1997
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Screening for Psychotherapeutic Medication Misuse in Primary Care Patients: Comparing Two Instruments  
    Wally R Smith, Sebastian T Tong, Journal of The American Board of Family Medicine
  • A Phase 3 Trial of L-glutamine in Sickle Cell Disease  
    Rita Bellevue, Joseph L Lasky, Elliott P Vichinsky, Lewis L Hsu, Sharada Sarnaik, Lynne D Neumayr, Yutaka Niihara, Sophie Lanzkron, Ifeyinwa Osunkwo, Lance Sieger, Edu..., The New England Journal of Medicine

Abstracts/Posters

  • Development and Validation of a Functional Status-Based Pain Assessment Tool
    Wally R Smith, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Severity Classification for Sickle Cell Disease: A RAND/UCLA Modified Delphi Panel
    Wally R Smith, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Crizanlizumab Versus Placebo, with or without Hydroxyurea/Hydroxycarbamide, in Adolescent and Adult Patients with Sickle Cell Disease and Vaso-Occlusive Crises: A Rand...
    Wally R Smith, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • The Effect of Patient Navigators on Laboratory Parameters of Hydroxyurea Adherence in Sickle Cell Anemia: The SHIP-HU Study 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Case Management Featuring Community Health Workers Reduces Inpatient Health Care Utilization in Adults with Sickle Cell Disease 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • The Effect of Patient Navigators on Laboratory Parameters of Hydroxyurea Adherence in Sickle Cell Anemia: The SHIP-HU Study 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Join now to see all

Press Mentions

  • Provider Conference Expands Impact of College of Nursing’s Sickle Cell Disease Education
    Provider Conference Expands Impact of College of Nursing’s Sickle Cell Disease EducationMarch 26th, 2025
  • Promising New Sickle Cell Therapy Trialed at Children's Hospital of Richmond at VCU and VCU Medical Center
    Promising New Sickle Cell Therapy Trialed at Children's Hospital of Richmond at VCU and VCU Medical CenterDecember 18th, 2023
  • SGLT2 Inhibitors Reduces Hospitalization for Heart Failure Regardless of Presence of Diabetes
    SGLT2 Inhibitors Reduces Hospitalization for Heart Failure Regardless of Presence of DiabetesApril 11th, 2022
  • Join now to see all

Grant Support

  • Sickle Cell Disease Pain Analgesia And Integrative NetworkUNIVERSITY OF CALIFORNIA-IRVINE2024–2029
  • Sickle Cell Disease Pain Analgesia And Integrative NetworkUNIVERSITY OF CALIFORNIA-IRVINE2024–2029
  • Sickle Cell Disease Pain Analgesia And Integrative NetworkUNIVERSITY OF CALIFORNIA-IRVINE2024–2029
  • Virginia Basic And Translational Research ProgramNational Heart, Lung, And Blood Institute2009–2011
  • Career Development For A Sickle Cell ScholarNational Heart, Lung, And Blood Institute2008–2011
  • Administrative CoreNational Heart, Lung, And Blood Institute2008–2011
  • Morphine Pharmacokinetics And Pharmacodynamics In Sickle Cell DiseaseNational Center For Research Resources2010
  • Comparative Effectiveness Of Virginia Coordinated Care Versus The Traditional SAFAgency For Healthcare Research And Quality2010
  • Virginia Comprehensive Sickle Cell Center-Center: Basic &Translational ResearchNational Heart, Lung, And Blood Institute2008
  • Virginia Commonwealth University Sickle Cell Disease Clinical NetworkNational Heart, Lung, And Blood Institute2007–2008
  • Virginia Commonwealth University Sickle Cell DiseaseNational Heart, Lung, And Blood Institute2006
  • Multi-Center Study Of Hydroxyurea In Sickle Cell Anemia (MSH) Patients FollowNational Center For Research Resources2006
  • Pain In Sickle Cell Epidemiology Study (PISCES)National Center For Research Resources2004
  • Pain In Sickle Cell Epidemiologic StudyNational Heart, Lung, And Blood Institute2001–2003
  • Multicenter Study Of Hydroxyurea 5 Years Follow-Up StudyNational Center For Research Resources1998–2001

Dr. Wally Smith, Dr. Wally Smith, MD, Dr. W Smith, Dr. Wally R Smith